The cystic renal disorders are a heterogeneous and hereditary disease described by cystic changes in the kidneys. The two major inherited types are the autosomal recessive polycystic kidney disease (ARPKD) and autosomal dominant polycystic kidney disease (
1,
2). The autosomal recessive polycystic kidney disease is a comparatively usual form of the childhood polycystic kidney disease and the frequency of it is 1: 20 000 in neonates (
3). Different degrees of hepatic anomalies are connected with renal changes in ARPKD, biliary dysgenesis and hepatic fibrosis are included (
4). The kidneys are enlarged, with small cysts, < 5 mm, limited to the collecting tubules (
5). The autosomal recessive polycystic kidney disease is most often diagnosed by third trimester antenatal ultrasounds that may demonstrate oligohydramnios, flank masses, or absence of fetal vesicle filling. If it remains antenatally undiagnosed, delivery of neonates may be difficult due to large masses in flank (
4). Palpable masses in flank and a large liver are the most usual primary presentations of ARPKD leading to respiratory insufficiency, hypertension and urinary tract infections (
3). The autosomal recessive polycystic kidney disease may followed by electrolyte abnormalities, pulmonary hypoplasia, oligohydramnious and the Potter’s syndrome (
6). Thirty percent of patients who present with large kidneys die in the infancy due to respiratory inadequacy and presumably many of these cases have undiagnosed ARPKD (
4). Different mutations of PKHD1 are known that can cause ARPKD and their average detection rate is almost 85% (
7). On the other hand, mutations in PKHD1 have also been identified in about 30% of children with congenital hepatic fibrosis (the Caroli’s syndrome) without evident kidney involvement (
5). In recent years, molecular analysis of patients and comprehensive studies of sibling have shown the effect of the factors described in a variety of monogenic diseases. Exploration of the genetic cause of the polycystic kidney disease (PKD) in humans revealed that genotype-phenotype correlations are now possible in these disorders. It is certainly estimated that nongenetic factors, including environmental exposures, significantly influence the severity of renal disease and other extrarenal manifestations in PKD (
8).